| __timestamp | Wave Life Sciences Ltd. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2395000 | 396000000 |
| Thursday, January 1, 2015 | 9057000 | 364000000 |
| Friday, January 1, 2016 | 40818000 | 376000000 |
| Sunday, January 1, 2017 | 79309000 | 382000000 |
| Monday, January 1, 2018 | 134428000 | 432000000 |
| Tuesday, January 1, 2019 | 175431000 | 457000000 |
| Wednesday, January 1, 2020 | 130944000 | 463000000 |
| Friday, January 1, 2021 | 121875000 | 508000000 |
| Saturday, January 1, 2022 | 115856000 | 539000000 |
| Sunday, January 1, 2023 | 130009000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Zoetis Inc. and Wave Life Sciences Ltd. have demonstrated contrasting approaches to R&D investment.
Zoetis Inc., a leader in animal health, has consistently increased its R&D spending, with a notable 55% rise from 2014 to 2023. This steady growth underscores Zoetis's dedication to advancing veterinary medicine and maintaining its competitive edge.
Conversely, Wave Life Sciences Ltd., a biotechnology firm, has experienced a more volatile R&D trajectory. Despite a staggering 7,300% increase from 2014 to 2019, their expenses have fluctuated, reflecting the inherent risks and rewards of pioneering genetic medicine.
These trends highlight the diverse strategies companies employ to drive innovation and shape the future of healthcare.
Research and Development Investment: Sanofi vs Wave Life Sciences Ltd.
R&D Spending Showdown: Bristol-Myers Squibb Company vs Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Wave Life Sciences Ltd.
Research and Development Expenses Breakdown: Summit Therapeutics Inc. vs Wave Life Sciences Ltd.
R&D Insights: How CRISPR Therapeutics AG and Wave Life Sciences Ltd. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Catalyst Pharmaceuticals, Inc. and Wave Life Sciences Ltd.
Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Wave Life Sciences Ltd. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?